Abstract
The 5-year results of the CMF adjuvant program carried out in Milan have shown significantly better relapse-free (RFS) and total survival rates in women with positive axillary nodes who were treated with 12 cycles of combination chemotherapy following radical mastectomy than in those treated only with surgery [1, 11]. The 5-year results were subsequently confirmed in the 6-year analysis [2].
This work was supported in part by contract no. N01-CM-07388 with NCI, DCT, NIH, Bethesda, MD, USA
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bonadonna G, Valagussa P (1981) Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304: 10–15
Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambilla C, Marchini S, Veronesi U (1981) Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes. The Milan Institute experience. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer III. Grune and Stratton, New York, pp. 435–444
Bonadonna G, Valagussa P, Tancini G, Di Fronzo G (1980) Estrogen-receptor status and response to chemotherapy in early and advanced breast cancer. Cancer Chemother Pharmacol 4: 37–41
Cooke T, George D, Shields R, Maynard P, Griffiths K (1979) Oestrogen receptors and prognosis in early breast cancer. Lancet 1: 995–997
Fisher B, Slack N, Katrych D, Wolmark N (1975) Ten-year follow up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 140: 528–534
Fisher ER, Redmond C, Fisher B (1980) Pathological findings from the National Surgical Adjuvant Breast Project (Protocol no. 4) VI. Discriminant for five-year treatment failure. Cancer 46: 908–918
Goldie GH, Coldman AJ (1979) A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727–1733
Knight WA, Livingston RB, Gregory EJ, McGuire WL (1977) Estrogen receptor: an independent prognostic factor for early recurrence in breast cancer. Cancer Res 37: 4669–4671
Meyer JS, Rao BR, Stevens SC, White WL (1977) Low incidence of estrogen receptors in breast carcinomas with rapid rates of cellular replication. Cancer 40: 2290–2298
Nime FA, Rosen PP, Thaler H, Ashikary R, Urban JA (1977) Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma. Am J Surg Pathol 1: 25–30
Rossi A, Bonadonna G, Valagussa P, Veronesi U (1981) Multimodal treatment in operable breast cancer: five-year results of the CMF programme. Br Med J 282: 1427–1431
Santoro A, Bonadonna G, Bonfante V, Valagussa P (1982) Alternating non-cross resistant chemotherapy vs MOPP alone in the treatment of advanced Hodgkin’s disease. New Engl J Med 306: 770–775
Skipper HE (1980) Breast cancer treated by means of mastectomy and mastectomy followed by 12 or 6 cycles of CMF. Southern Research Institute Birmingham, Ala
Silvestrini R, Daidone MG, Di Fronzo G (1979) Relationship between proliferative activity and estrogen receptors in breast cancer. Cancer 44: 665–670
Special Report (1979) Treatment of primary breast cancer. N Engl J Med 301: 340
National Institute of Health (1980) Steroid receptors in breast cancer. An NIH consensus development conference. Bethesda, Maryland, 27—29 Juni, 1979. Cancer (Suppl) 46: 2759–2962
Valagussa P, Bonadonna G, Veronesi U (1978) Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41: 1170–1178
Valagussa P, Di Fronzo G, Bignami P, Buzzoni R, Bonadonna G, Veronesi U (1981) Prognostic importance of estrogen receptors to select node negative patients for adjuvant chemotherapy. In: Salmon, SE, Jones SE (eds) Adjuvant therapy of cancer III. Grune and Stratton, New York, pp. 329–333
Veronesi U, Saccozzi R, Del Vecchio M, Banfi A, Clemente M, De Lena M, Gallus G, Greco M, Luini A, Marubini E, Muscolino G, Rilke F, Salvadori B, Zecchini A, Zucali R (1981) Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancer of the breast. N Engl J Med 305: 6–11
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Bonadonna, G., Bignami, P., Buzzoni, R., Moliterni, A., Valagussa, P., Veronesi, U. (1984). New Adjuvant Trials for Resectable Breast Cancer at the Istituto Nazionale Tumori of Milan. In: Leclercq, G., Toma, S., Paridaens, R., Heuson, J.C. (eds) Clinical Interest of Steroid Hormone Receptors in Breast Cancer. Recent Results in Cancer Research, vol 91. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82188-2_29
Download citation
DOI: https://doi.org/10.1007/978-3-642-82188-2_29
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82190-5
Online ISBN: 978-3-642-82188-2
eBook Packages: Springer Book Archive